Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/<i>neu</i> Transgenic Mice
1998 · The Journal of Experimental Medicine · 300 citations
https://doi.org/10.1084/jem.188.3.589
G
Giordano Nicoletti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
231
Papers
6.0K
Citations
45
h-index
108
i10-index
Giordano Nicoletti is an academic researcher from Istituto Ortopedico Rizzoli. The author has contributed to research in topics: Immunotherapy and Immune Responses & Sarcoma Diagnosis and Treatment & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 45, co-authored 197 publications.
ORCID: 0000-0001-7050-7833Papers by this author
worksImmunoprevention of Mammary Carcinoma in HER-2/ <i>neu</i> Transgenic Mice Is IFN-γ and B Cell Dependent
2004 · The Journal of Immunology · 90 citations
https://doi.org/10.4049/jimmunol.173.4.2288
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells
2009 · Proceedings of the National Academy of Sciences · 88 citations
https://doi.org/10.1073/pnas.0812268106
Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells
2013 · Cancer & Metabolism · 87 citations
https://doi.org/10.1186/2049-3002-1-11
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma
2000 · International Journal of Cancer · 84 citations
https://doi.org/10.1002/1097-0215(20000715)87:2<186::aid-ijc5>3.0.co;2-1
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
2015 · Oncotarget · 72 citations
https://doi.org/10.18632/oncotarget.5793
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat